Login to Your Account



Bill would restrict prosecution for off-label communication

By Mark McCarty
Regulatory Editor

Thursday, April 6, 2017

With the off-label/intended use controversy still simmering, a bill has debuted in the U.S. House of Representatives that would restrict the federal government's ability to pursue charges against manufacturers of drugs and devices.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription